A mom was overjoyed when she learned a drug could save her baby's life. Then she learned it cost $2 million. [CBS News]
Breakthrough genetic therapies can save lives, but many cost millions for single dose [CBS News]
Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
Sarepta Therapeutics (SRPT): Reassessing Valuation After a Sharp One-Month Share Price Rebound [Yahoo! Finance]
Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Wedbush. They set an "outperform" rating and a $32.00 price target on the stock.